{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T20:21:49Z","timestamp":1760300509653,"version":"build-2065373602"},"reference-count":15,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Auris Nasus Larynx"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.anl.2020.10.005","type":"journal-article","created":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T17:18:31Z","timestamp":1603559911000},"page":"515-519","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["A long survival patient of anaplastic thyroid carcinoma treated with lenvatinib"],"prefix":"10.1016","volume":"49","author":[{"given":"Takao","family":"Hamamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Taruya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Ishino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachio","family":"Takeno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anl.2020.10.005_bib0001","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.clon.2010.03.013","article-title":"Anaplastic thyroid carcinoma: pathogenesis and emerging therapies","volume":"22","author":"Smallridge","year":"2010","journal-title":"Clin Oncol"},{"key":"10.1016\/j.anl.2020.10.005_bib0002","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s002680020166","article-title":"Prognostic factors and therapeutic strategy for anaplastic carcinoma of the thyroid","volume":"25","author":"Sugitani","year":"2001","journal-title":"World J Surg"},{"key":"10.1016\/j.anl.2020.10.005_bib0003","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hed.23295","article-title":"Super-radical surgery for anaplastic thyroid carcinoma: a large cohort study using the anaplastic thyroid carcinoma research consortium of Japan database","volume":"36","author":"Sugitani","year":"2014","journal-title":"Head Neck"},{"key":"10.1016\/j.anl.2020.10.005_bib0004","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1007\/s00268-014-2536-9","article-title":"Anaplastic thyroid carcinomas incidentally found on postoperative pathological examination","volume":"38","author":"Yoshida","year":"2014","journal-title":"World J Surg"},{"key":"10.1016\/j.anl.2020.10.005_bib0005","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2174\/138920211798120853","article-title":"Genetic alterations in poorly differentiated and undifferentiated thyroid carcinomas","volume":"12","author":"Soares","year":"2011","journal-title":"Curr Genom"},{"key":"10.1016\/j.anl.2020.10.005_bib0006","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(14)60421-9","article-title":"DECISION investigators: sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomized, double-blind, phase 3 trial","volume":"384","author":"Brose","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.anl.2020.10.005_bib0007","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1056\/NEJMoa1406470","article-title":"Lenvatinib versus placebo in radioiodine-refractory thyroid cancer","volume":"372","author":"Schlumberger","year":"2015","journal-title":"N Eng J Med"},{"key":"10.1016\/j.anl.2020.10.005_bib0008","doi-asserted-by":"crossref","first-page":"iv343","DOI":"10.1093\/annonc\/mdu340.10","article-title":"Phase 2 study of lenvatinib, a multi-targeted tyrosine kinase inhibitor, in patients with all histologic subtypes of advanced thyroid cancer","volume":"25","author":"Takahashi","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.anl.2020.10.005_bib0009","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fonc.2017.00025","article-title":"Lenvatinib for anaplastic thyroid cancer","volume":"7","author":"Tahara","year":"2017","journal-title":"Front Oncol"},{"key":"10.1016\/j.anl.2020.10.005_bib0010","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000485972","article-title":"Lenvatinb for anaplastic thyroid cancer and lenvatinib-induced thyroid dysfunction","volume":"7","author":"Koyama","year":"2018","journal-title":"Eur Thyroid J"},{"key":"10.1016\/j.anl.2020.10.005_bib0011","first-page":"7271","article-title":"Lenvatinib as a novel treatment for anaplastic thyroid cancer: a retrospective study","volume":"16","author":"Iwasaki","year":"2018","journal-title":"Oncol lett"},{"key":"10.1016\/j.anl.2020.10.005_bib0012","first-page":"16","article-title":"Efficacy of lenvatinib in a patient with anaplastic thyroid cancer","volume":"2017","author":"Oishi","year":"2017","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"10.1016\/j.anl.2020.10.005_bib0013","first-page":"18","article-title":"Rapid pleural effusion after discontinuation of lenvatinib in a patient with pleural metastasis from thyroid cancer","volume":"2019","author":"Uchida","year":"2019","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"10.1016\/j.anl.2020.10.005_bib0014","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1002\/ijc.32041","article-title":"Anti-PD-1\/ PD-L1 therapy augments lenvatinib's efficacy by favorably altering the immune microenvironment of murine anaplastic thyroid cancer","volume":"144","author":"Gunda","year":"2018","journal-title":"Int J Cancer"},{"key":"10.1016\/j.anl.2020.10.005_bib0015","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1272\/jnms.2018_85-3","article-title":"Management of anaplastic thyroid carcinoma: the fruits from the ATC Research consortium of Japan","volume":"85","author":"Sugitani","year":"2018","journal-title":"J Nippon Med Sch"}],"container-title":["Auris Nasus Larynx"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S038581462030273X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S038581462030273X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T19:38:28Z","timestamp":1759952308000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S038581462030273X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S038581462030273X"],"URL":"https:\/\/doi.org\/10.1016\/j.anl.2020.10.005","relation":{},"ISSN":["0385-8146"],"issn-type":[{"type":"print","value":"0385-8146"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A long survival patient of anaplastic thyroid carcinoma treated with lenvatinib","name":"articletitle","label":"Article Title"},{"value":"Auris Nasus Larynx","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anl.2020.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Japanese Society of Otorhinolaryngology-Head and Neck Surgery, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}